5965-66-2 Usage
Description
BETA-D-LACTOSE, also known as the beta-anomer of lactose, is a white solid that is a disaccharide sugar found in milk and dairy products. It is an essential component of the mammalian digestive system, as it serves as a primary source of energy for infants. The chemical structure of BETA-D-LACTOSE allows it to interact with various substances, making it a versatile compound with a wide range of applications.
Uses
Used in Pharmaceutical Industry:
BETA-D-LACTOSE is used as a nutrient and a filler in the pharmaceutical industry for the production of tablets. Its presence in pills provides a source of energy and enhances the overall formulation of the medication.
Used in Food and Beverage Industry:
BETA-D-LACTOSE is used as a sweetening agent in the food and beverage industry, particularly for stout beer. Its natural sweetness adds flavor and enhances the taste of the beverage.
Used in Illicit Drug Preparation:
Although not a legal or ethical application, BETA-D-LACTOSE is utilized in the dilution of heroin, which is an illicit drug. This use highlights the versatility of the compound but also emphasizes the importance of responsible and ethical use of chemicals.
Biochem/physiol Actions
Beta-Lactose is the beta-pyranose form of the compound lactose.
Check Digit Verification of cas no
The CAS Registry Mumber 5965-66-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,6 and 5 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5965-66:
(6*5)+(5*9)+(4*6)+(3*5)+(2*6)+(1*6)=132
132 % 10 = 2
So 5965-66-2 is a valid CAS Registry Number.
5965-66-2Relevant articles and documents
PHARMACEUTICAL ANTIRETROVIRAL COMPOSITION
-
Page/Page column, (2014/07/22)
The present invention relates to a pharmaceutical antiretroviral composition comprising (i) a nucleoside reverse-transcriptase inhibitor selected from lamivudine and emtricitabine, (ii) extended release nevirapine, and (iii) tenofovir; a process for preparing such composition and the use of such composition in medicine, particularly for the prophylaxis and/or treatment of diseases caused by retroviruses.
Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea L. Var. Edulis extract
-
, (2010/04/23)
Disclosed herein is a pharmaceutical composition having preventative and therapeutic effects on liver diseases, comprising an extract from Lonicera caerulea L. var. edulis. The composition has preventative and therapeutic effects on hepatitis, liver cirrhosis, fatty liver, and the like.
Synthesis and characterization of bis(glycosylamino)benzenes based on reducing disaccharides
Metlitskikh,Koroteev,Nifantyev
, p. 1272 - 1275 (2007/10/03)
Synthesis of bis(glycosylamino)benzenes, derived from disaccharides lactose, maltose, and cellobiose, by direct condensation and their characterization are described.
